0001562180-20-006997.txt : 20201201 0001562180-20-006997.hdr.sgml : 20201201 20201201214326 ACCESSION NUMBER: 0001562180-20-006997 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201127 FILED AS OF DATE: 20201201 DATE AS OF CHANGE: 20201201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Woock John CENTRAL INDEX KEY: 0001756437 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38721 FILM NUMBER: 201362279 MAIL ADDRESS: STREET 1: 26 TECHNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axonics Modulation Technologies, Inc. CENTRAL INDEX KEY: 0001603756 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 454744083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 TECHNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-396-6322 MAIL ADDRESS: STREET 1: 26 TECHNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92618 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-11-27 false 0001603756 Axonics Modulation Technologies, Inc. AXNX 0001756437 Woock John 26 TECHNOLOGY DRIVE IRVINE CA 92618 false true false false Chief Marketing Officer Common Stock 2020-11-27 4 M false 10000.00 1.42 A 77348.00 D Common Stock 2020-11-27 4 S false 2400.00 43.7946 D 74948.00 D Common Stock 2020-11-27 4 S false 100.00 45.49 D 74848.00 D Common Stock 2020-11-27 4 S false 7500.00 44.9414 D 67348.00 D Stock Option (Right to Buy) 1.42 2020-11-27 4 M false 10000.00 0.00 D 2027-08-25 Common Stock 10000.00 4178.00 D This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 22, 2020. This transaction was executed in multiple trades at prices ranging from $43.36 to $44.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $44.47 to $45.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The shares subject to the option vest over a period of four years. 7,800 of the shares subject to the option vested on July 21, 2017 and the remainder vest at a rate of 1/36th per month commencing on July 21, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable. /s/ Dan Dearen, as Attorney-in-Fact for John Woock, Ph.D 2020-12-01